Recent Updates
Recently added Catalysts
IDXX Positive Sentiment

IDEXX erweitert den Fecal Dx Antigentest um den Nachweis von Taeniid-Bandwürmern

Thursday, September 24, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: IDEXX Laboratories has announced an expansion of its Fecal Dx Antigentest in Germany to include the detection of Taeniid tapeworms, such as Taenia and Echinococcus spp. This enhancement allows the test to identify intestinal parasite infections at an earlier stage, demonstrating up to double the detection rate compared to traditional flotation methods.

Market Sentiment Analysis

POSITIVE FACTORS

  • IDEXX expands its Fecal Dx Antigentest capabilities.
  • The test detects Taeniid tapeworms effectively.
  • It identifies intestinal parasite infections earlier.
  • The test shows improved detection rates compared to flotation.

Full Press Release Details

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), global führend bei Innovationen im Bereich der Tiergesundheit, gab heute in Deutschland die Erweiterung seines Fecal Dx™ Antigentests für Taeniid-Bandwürmer, einschließlich Taenia und Echinococcus spp., bekannt. Es wurde nachgewiesen, dass der Fecal Dx Antigentest im Vergleich zur alleinigen Flotation bis zu doppelt so viele Infektionen mit Darmparasiten in einem früheren Stadium erkennt.1 Mit einer einzigen Untersuchun

Frequently Asked Questions

What is the Fecal Dx Antigentest?

The Fecal Dx Antigentest is a diagnostic tool developed by IDEXX for detecting intestinal parasites.

What new capabilities does the test have?

The test now includes the detection of Taeniid tapeworms, including Taenia and Echinococcus spp.

How does the test compare to traditional methods?

It detects up to double the number of infections at an earlier stage compared to flotation methods.

Where was this expansion announced?

The expansion of the Fecal Dx Antigentest was announced in Germany.

ShareAdd on Google
Tags: IDXX Viatris Investor Conferences Healthcare IDEXX Fecal Dx Taeniid tapeworms Echinococcus animal health
Last updated: Sep 24, 2026

Biotech snapshot

Cash runway
$197M liquidity · $0M/mo burn
Low dilution risk